138 related articles for article (PubMed ID: 6185767)
21. Plasma high-density lipoproteins and liver lipids and proteins in man. Relation to hepatic histology and microsomal enzyme induction.
Luoma PV; Savolainen MJ; Sotaniemi EA; Pelkonen RO; Arranto AJ; Ehnholm C
Acta Med Scand; 1983; 214(2):103-9. PubMed ID: 6624542
[TBL] [Abstract][Full Text] [Related]
22. Antiepileptic drug distribution in cerebral cortex, ammon's horn, and amygdala in man.
Sironi VA; Cabrini G; Porro MG; Ravagnati L; Marossero F
J Neurosurg; 1980 May; 52(5):686-92. PubMed ID: 7373396
[TBL] [Abstract][Full Text] [Related]
23. Serum phenytoin, phenobarbital, carbamazepine, albumin; and plasma estradiol, progesterone concentrations during the menstrual cycle in women with epilepsy.
Bäckström T; Jorpes P
Acta Neurol Scand; 1979 Mar; 59(2-3):63-71. PubMed ID: 452841
[TBL] [Abstract][Full Text] [Related]
24. The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteins.
Luoma PV; Marniemi J; Sotaniemi EA
Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):125-8. PubMed ID: 3144720
[TBL] [Abstract][Full Text] [Related]
25. Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants.
Verrotti A; Domizio S; Angelozzi B; Sabatino G; Morgese G; Chiarelli F
J Paediatr Child Health; 1997 Jun; 33(3):242-5. PubMed ID: 9259301
[TBL] [Abstract][Full Text] [Related]
26. Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study.
Sudhop T; Bauer J; Elger CE; von Bergmann K
Epilepsia; 1999 Apr; 40(4):480-4. PubMed ID: 10219275
[TBL] [Abstract][Full Text] [Related]
27. [Plasma levels of anticonvulsants. Experiences with routine plasma level determination of 6 different anticonvulsants].
Klotz U
Fortschr Med; 1978 Jan; 96(1):9-13. PubMed ID: 340366
[No Abstract] [Full Text] [Related]
28. Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes.
Sonmez FM; Demir E; Orem A; Yildirmis S; Orhan F; Aslan A; Topbas M
J Child Neurol; 2006 Jan; 21(1):70-4. PubMed ID: 16551457
[TBL] [Abstract][Full Text] [Related]
29. Relationships between plasma concentrations of diphenylhydantoin, phenobarbital, carbamazepine, and 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810), a new anticonvulsant agent, and their anticonvulsant or neurotoxic effects in experimental animals.
Masuda Y; Utsui Y; Shiraishi Y; Karasawa T; Yoshida K; Shimizu M
Epilepsia; 1979 Dec; 20(6):623-33. PubMed ID: 115675
[TBL] [Abstract][Full Text] [Related]
30. Development, validation and clinical application of an online-SPE-LC-HRMS/MS for simultaneous quantification of phenobarbital, phenytoin, carbamazepine, and its active metabolite carbamazepine 10,11-epoxide.
Qu L; Fan Y; Wang W; Ma K; Yin Z
Talanta; 2016 Sep; 158():77-88. PubMed ID: 27343581
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic plasma levels of phenytoin, phenobarbital, and carbamazepine: individual variation in relation to seizure frequency and type.
Schmidt D; Haenel F
Neurology; 1984 Sep; 34(9):1252-5. PubMed ID: 6540414
[TBL] [Abstract][Full Text] [Related]
32. Microsomal enzyme induction, lipoproteins and atherosclerosis.
Luoma PV
Pharmacol Toxicol; 1988 May; 62(5):243-9. PubMed ID: 3045791
[TBL] [Abstract][Full Text] [Related]
33. Indications of anticonvulsant plasma levels monitoring in medical and surgical treatment of epilepsy.
Cabrini GP; Sironi VA; Marossero F; Baruzzi A
J Neurosurg Sci; 1979; 23(1):29-36. PubMed ID: 536747
[TBL] [Abstract][Full Text] [Related]
34. Use of total and free anticonvulsant serum levels in clinical practice.
Beran RG; Lewis JH; Nolte JL; Westwood AP
Clin Exp Neurol; 1985; 21():69-77. PubMed ID: 3939613
[TBL] [Abstract][Full Text] [Related]
35. Microdialysis sampling of carbamazepine, phenytoin and phenobarbital in subcutaneous extracellular fluid and subdural cerebrospinal fluid in humans: an in vitro and in vivo study of adsorption to the sampling device.
Lindberger M; Tomson T; Lars S
Pharmacol Toxicol; 2002 Oct; 91(4):158-65. PubMed ID: 12530465
[TBL] [Abstract][Full Text] [Related]
36. Comparison between premortem and postmortem serum concentrations of phenobarbital, phenytoin, carbamazepine and its 10,11-epoxide metabolite in institutionalized patients with epilepsy.
May T; Jürgens U; Rambeck B; Schnabel R
Epilepsy Res; 1999 Jan; 33(1):57-65. PubMed ID: 10022366
[TBL] [Abstract][Full Text] [Related]
37. Effects of phenytoin on serum gamma-glutamyl transpeptidase activity.
Sano J; Kawada H; Yamaguchi N; Kawakita M; Kobayashi K
Epilepsia; 1981 Jun; 22(3):331-8. PubMed ID: 6113134
[TBL] [Abstract][Full Text] [Related]
38. Serum lipid changes during anticonvulsive treatment serum lipids in epileptic children.
Yilmaz E; Doşan Y; Gürgöze MK; Güngör S
Acta Neurol Belg; 2001 Dec; 101(4):217-20. PubMed ID: 11851028
[TBL] [Abstract][Full Text] [Related]
39. Serum level of phenobarbital or/and diphenylhydantoin in epileptics with some preexisting serum lipid alterations. Correlations with the treatment efficiency in epilepsy.
Rogozea R; Florea-Ciocoiu V; Balaita C; Luca N
Acta Neurol Belg; 1981; 81(1):24-32. PubMed ID: 7223355
[TBL] [Abstract][Full Text] [Related]
40. Validated high performance liquid chromatographic method for simultaneous determination of phenytoin, phenobarbital and carbamazepine in human serum.
Kishore P; Rajnarayana K; Reddy MS; Sagar JV; Krishna DR
Arzneimittelforschung; 2003; 53(11):763-8. PubMed ID: 14677371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
